Consensus HealthEquity, Inc.

Equities

HQY

US42226A1079

Software

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-23 pm EST			5-day change	1st Jan Change
84.11 ^USD	-2.67%		-1.48%	-8.19%

Jan. 14	HealthEquity, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 03:00 PM
Jan. 12	HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2027	CI

Evolution of the Average Target: HealthEquity, Inc.

Evolution of the Target Price: HealthEquity, Inc.

Changes in Analyst Recommendations: HealthEquity, Inc.

85180f0f308822fe071cfe.1SF5BMDht6Ndkeu1MPAeWWikMyzJVvZXfn-YRmIlROI.thMYXZaT49Ea-pzTb4BGEhv0f2HxAr56NwfwMwpsAKXiFzJ8s43i-Qj7pg~6047dc7ef3e0b987121b4766c8992a8b

Analysts' recommendations: HealthEquity, Inc.

Jan. 09	HealthEquity Shares Fall After Goldman Sachs Downgrade	MT
Jan. 09	Goldman Sachs Downgrades HealthEquity to Sell From Neutral, Adjusts Price Target to $89 From $113	MT
Dec. 09	Barclays Initiates HealthEquity With Overweight Rating, $118 Price Target	MT
Dec. 05	Deutsche Bank Adjusts Price Target on HealthEquity to $120 From $117, Maintains Buy Rating	MT
Nov. 13	BMO Capital Initiates Coverage on HealthEquity With Market Perform Rating	MT
25-09-05	Deutsche Bank Lifts Price Target on HealthEquity to $117 From $115, Keeps Buy Rating	MT
25-09-03	RBC Lifts Price Target HealthEquity to $110 From $109, Keeps Outperform Rating	MT
25-09-02	Health-savings account manager HealthEquity Q2 revenue beats estimates	RE
25-08-28	RBC Lowers Price Target on HealthEquity to $109 From $117, Keeps Outperform Rating	MT
25-06-06	Barrington Adjusts Price Target on HealthEquity to $125 From $112, Maintains Outperform Rating	MT
25-06-05	Deutsche Bank Adjusts HealthEquity Price Target to $115 From $98, Maintains Buy Rating	MT
25-06-05	Analyst recommendations: Microsoft, Nvidia, Visa, Dollar Tree, Roblox…
25-06-04	HealthEquity Shares Rise After RBC Price Target Raise	MT
25-06-04	RBC Raises Price Target on HealthEquity to $117 From $112, Keeps Outperform Rating	MT
25-05-22	RBC Raises Price Target on HealthEquity to $112 From $105, Keeps Outperform Rating	MT
25-03-25	Raymond James Upgrades HealthEquity to Strong Buy From Outperform, Adjusts Price Target to $115 From $120	MT
25-03-25	Raymond James Upgrades HealthEquity to Strong Buy From Outperform, Price Target is $115	MT
25-03-20	Deutsche Bank Lowers Price Target on HealthEquity to $98 From $108, Keeps Buy Rating	MT
25-01-14	Deutsche Bank Adjusts HealthEquity Price Target to $108 From $103, Maintains Buy Rating	MT
24-12-10	Barrington Research Cuts HealthEquity Price Target to $112 From $120, Maintains Outperform Rating	MT
24-12-10	RBC Raises Price Target on HealthEquity to $105 From $100, Keeps Outperform Rating	MT
24-12-04	Mizuho Initiates HealthEquity at Outperform With $126 Price Target	MT
24-12-02	Analyst recommendations: Cloudflare, Toast, Netflix, Robinhood, HSBC...
24-09-19	HealthEquity Positioned to Weather Fed Rate Cuts, RBC Says	MT
24-09-19	RBC Raises Price Target on HealthEquity to $100 From $92, Keeps Outperform Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	HEALTHEQUITY, INC.					+41.63%
	MICROSOFT CORPORATION					+32.6%
	PALANTIR TECHNOLOGIES INC.					+12.18%
	SYNOPSYS, INC.					+10.82%
	CADENCE DESIGN SYSTEMS, INC.					+19.79%
	CAMBRICON TECHNOLOGIES CORPORATION LIMITED					+44.41%
	SEA LIMITED					+52.3%
	ROBLOX CORPORATION					+80.14%
	TAKE-TWO INTERACTIVE SOFTWARE, INC.					+13.11%
	DASSAULT SYSTÈMES SE					+27.42%
	Average					+33.44%
	Weighted average by Cap.					+30.86%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

84.11USD

Average target price

119.12USD

Spread / Average Target

+41.63%

High Price Target

130.00USD

Spread / Highest target

+54.56%

Low Price Target

86.00USD

Spread / Lowest Target

+2.25%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Goldman Sachs
Barclays
Deutsche Bank Securities
BMO Capital
RBC Capital Markets
Barrington Research
Raymond James
Mizuho Securities
Wells Fargo Securities
KeyBanc Capital Markets
JMP Securities
JPMorgan Chase
Jefferies & Co.
BTIG
Baird
Guggenheim
SVB Securities LLC
BofA Securities
Stephens Inc.
SVB Leerink
Cantor Fitzgerald